Journals / İstanbul Medical Journal / 2022 / Cilt: 23 - Sayı: 1

Correlation of Coronary Calcium Scores with Growth Differentiation Factor-15 Levels in Patients with Coronary Artery Disease

Pages
74–78
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Leukocytes, GDF-15 levels, and monocyte/high-density lipoprotein-cholesterol (HDL-C) ratio were significantly higher in the CACS group (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: As noted in the guidelines, the efficacy of coronary artery calcium score (CACS) is remarkable in the intermediate-risk group for coronary artery disease; however, it exposes the patients to radiation.
📊
Key Findings & Data:In this study, we aimed to investigate whether growth differentiation factor-15 (GDF-15) could be an alternative to CACS in patients with traditional cardiovascular risk factors.
💡
Conclusion & Impact:Leukocytes, GDF-15 levels, and monocyte/high-density lipoprotein-cholesterol (HDL-C) ratio were significantly higher in the CACS group (p
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: As noted in the guidelines, the efficacy of coronary artery calcium score (CACS) is remarkable in the intermediate-risk group for coronary artery disease; however, it exposes the patients to radiation. In this study, we aimed to investigate whether growth differentiation factor-15 (GDF-15) could be an alternative to CACS in patients with traditional cardiovascular risk factors. Methods: In 2018, 86 volunteer patients (female: n=36; male: n=50) aged 25-85 years were included in the study among all patients whose CACS measurements were made in the radiology clinic. In our hospital, CACS images are obtained using 64-slice computed tomography. Serum GDF-15 levels were measured from venous blood. Participants were divided into two groups as zero and high (>0) according to the CACS. SPSS 21.0 was used for the statistical analysis. Results: Participants were compared with zero (female: n=16; male: n=17; mean age: 53.93 years) and high (>0) (female: 20, male: 33; mean age: 58.2 years) CACS groups. Leukocytes, GDF-15 levels, and monocyte/high-density lipoprotein-cholesterol (HDL-C) ratio were significantly higher in the CACS group (p

🔖

Cite This Article

KARABAĞ, T., HACOĞLU, Y., RAKICI, İ. T., KARATAŞ, S., PİŞKİNPAŞA, M. E., KILIÇKAYA, P. (2022). Correlation of Coronary Calcium Scores with Growth Differentiation Factor-15 Levels in Patients with Coronary Artery Disease. İstanbul Medical Journal, Cilt: 23 - Sayı: 1, 74–78. https://ajindex.com/articles/551751

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Goff DC Jr, Lloyd-Jones DM, Bennett G, Coady S, D’Agostino RB, Gibbons R, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129: 49-73
  2. Ago T, Sadoshima J. GDF15, a cardioprotective TGF-beta superfamily protein. Circ Res 2006; 98: 294-7
  3. Zhang S, Dai D, Wang X, Zhu H, Jin H, Zhao R, et al. Growth differentiation factor-15 predicts the prognoses of patients with acute coronary syndrome: a meta-analysis. BMC Cardiovasc Disord 2016; 16: 82
  4. Rosner B. Fundamentals of Biostatistics. 7th ed. Boston, Boston: Brooks/Cole, Cengage Learning; 2011
  5. Matsuzawa Y, Lerman A. Endothelial dysfunction and coronary artery disease: assessment, prognosis, and treatment. Coron Artery Dis 2014; 25: 713-24
  6. Greenland P, Blaha MJ, Budoff MJ, Erbel R, Watson KE. Coronary calcium score and cardiovascular risk. J Am Coll Cardiol 2018; 72: 434-47
  7. Degrell P, Sorbets E, Feldman LJ, Steg PG, Ducrocq G. Screening for coronary artery disease in asymptomatic individuals: Why and how? Arch Cardiovasc Dis 2015; 108: 675-82
  8. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-32
  9. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC. Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 2004; 291: 210-5
  10. Polonsky TS, McClelland RL, Jorgensen NW, Bild DE, Burke GL, Guerci AD, et al. Coronary artery calcium score and risk classification for coronary heart disease prediction. JAMA 2010; 303: 1610-6
  11. Erbel R, Möhlenkamp S, Moebus S, Schmermund A, Lehmann N, Stang A, et al. Heinz Nixdorf Recall Study Investigative Group. Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. J Am Coll Cardiol 2010; 56: 1397-406
  12. Sangiorgi G, Rumberger JA, Severson A, Edwards WD, Gregoire J, Fitzpatrick LA, et al. Arterial calcification and not lumen stenosis is highly correlated with atherosclerotic plaque burden in humans: a histologic study of 723 coronary artery segments using nondecalcifying methodology. J Am Coll Cardiol 1998; 31: 126-33
  13. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwart z RS. Coron